Nanoparticle-based dmg delivery systems

Journal of Controlled Release

Volumn 16, Issue 1-2, 1991, Pages 169-176

  Kreuter, Jörg ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Colloidal drug delivery system; Drug targeting; Nanoparticle; Vaccine adjuvant

Indexed keywords

ADJUVANT; AMPICILLIN; DACTINOMYCIN; DOXORUBICIN; DRUG CARRIER; FLUOROURACIL; INSULIN; METHOTREXATE; NANOPARTICLE; PILOCARPINE; POLY(ALKYL 2 CYANOACRYLATE); POLY(METHYL METHACRYLATE); UNCLASSIFIED DRUG; VACCINE;

CONFERENCE PAPER; DRUG ADMINISTRATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG TARGETING; EYE; INFLAMMATION; INFLUENZA VIRUS; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACEUTICS; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION; TOPICAL DRUG ADMINISTRATION;

EID: 0025760693     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(91)90040-K     Document Type: Article

References (63)

1. Evaluation of nanoparticles as drug-delivery systems I: Preparation methods
2. Über die Sarkomauslösung durch Fremdkörperimplantation bei Ratten in Abhängigkeit von der Form der Implantate
3. Sarkomerzeugung mit Fensterglas
4. The tissue reaction induced in rats and guinea-pigs by polymethylmethacrylate (acrylic) and stainless steel (18/8/mo)
5. The tissue reaction induced in guinea-pigs by particulate polymethylmethacrylate, polythene and nylon of the same size range
6. Preparation of injectable controlled-release microcapsules by a solvent-evaporation process
7. New adjuvants on a polymethyl (methacrylate) base
8. Mode of action of immunological adjuvants: Some physicochemical factors influencing the effectivity of polyacrylic adjuvants
9. Long-term studies of microen-capsulated and adsorbed influenza vaccine nanoparticles
10. 60Co-γ-irridation for the production of vaccines
11. Herstellung und In vitro-Prüfung von polymeren Adjuvantien für Impfstoffe
12. Distribution and elimination of poly (methyl methacrylate) nanoparticles after subcutaneous administration to rats
13. Pharmacokinetics and distribution of a biodegradable drug-carrier
14. Poly(alkyl acrylate) nanoparticles
15. Particle size and size distribution of poly(butyl-2-cyanoacrylate) nanoparticles. I. Influence of physicochemical factors
16. Particle size and size distribution of poly(butyl-2-cyanoacrylate) nano-particles. II. Influence of stabilizers
17. Development of a new process for the manufacture of polyisobutylcyanoacrylate nanoparticles
18. Nanoparticles — a new colloidal drug delivery system
19. Albumin microspheres for study of the re-ticuloendothelial system
20. Albumin microspheres as vehicles for achieving specificity in drug delivery
21. Magnetic microspheres: A model system for site specific drug delivery in vivo
22. Magnetic micro-spheres: Synthesis of a novel parenteral drug carrier
23. Analysis of albumin microsphere preparation
24. Evaluation of nanoparticles as drug-delivery-systems II: Comparison of the body distribution of nanoparticles with the body distribution of micro-spheres (diameter 〉 1 μm), liposomes, and emulsions
25. The biologic effects of polysterene latex particles administered intravenously to rats — a collaborative study
26. Distribution of radiolabelled subsieve microspheres after intravenous administration to Beagle dogs
27. Studies on the relationship between the electrophoretic properties of colloids and their blood clearance and organ distribution in the rat
28. The organ uptake of intravenously administered colloidal particles can be altered using a nonionic surfactant (poloxamer 338)
29. 14C-methacrylate) nanoparticles after intravenous injection in rats
30. Modification of the body distribution of poly (methyl methacrylate) nanoparticles in rats by coating with surfactants
31. 14C-methacrylate) nanoparticle radioactivity after injection in rats and mice
32. Biodegradable polymers for sustained drug delivery
33. Biodegradable polymeric nanoparticles as drug carrier for antitumor agents
34. Quantitative and microautoradiographic study on mouse intestinal distribution of polycyanoacrylate nanoparticles
35. Distribution and elimination of polymethyl methacrylate nanoparticles after peroral administration to rats
36. 14C]acrylate nanoparticles in the albino rabbit
37. 14C]acrylate nanoparticles in healthy and chronically inflamed rabbit eyes
38. Solid dispersion and solid solution
39. A solid colloidal drug delivery system for the eye: encapsulation of pilocarpine in nanoparticles
40. Distribution of polyhexyl cyanoacrylate nanoparticles in nude mice bearing human osteosarcoma
41. Distribution of polyhexylcyanoacrylate nanoparticles in nude mice bearing human osteosarcoma
42. Actinomycin D adsorbed on polymethylcyanoacrylate nanoparticles: Increased efficiency against an experimental tumor
43. Comparative study on the cytostatic effects and the tissue distribution of 5-fluorouracil in a free form and bound to polybutylcy-anoacrylate nanoparticles in Sarcoma 180-bearing mice
44. Drug-Carrier property of albumin micro-spheres in chemotherapy. III. Effect of microsphere-entrapped 5-fluorouracil on Ehrlich ascites carcinoma in mice
45. Toxicity of polyalkylcyanoacrylate nanoparticles II: Doxorubicin-loaded nanoparticles
46. Drug-Carrier property of albumin microspheres in chemotherapy. V. Antitumor effect of microsphere-entrapped adriamycin of liver metastasis of AH 7974 cells in rats
47. Factors influencing the body distribution of polyacrylic nanoparticles
48. Selective targeting of magnetic albumin microspheres containing low-dose adriamycin: Total remission in Yoshida sarcoma-bearing rats
49. Selective targeting of magnetic albumin microspheres to the Yoshida sarcoma: Ultrastructural evaluation of microsphere disposition
50. Effectiveness of nanoparticle-bound ampicillin in the treatment of Listeria monocytogenes infection in athymic nude mice
51. Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles
52. Development ofdehydroemetine nanoparticles for the treatment of visceral leishmaniasis
53. Disposition kinetics and oral bioavailability of vincamine-loaded polyalkyl cyanoacrylate nanoparticles
54. New Approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier
55. Comparison of different models for the testing of pilocarpine eyedrops using conventional eyedrops and a novel depot formulation (nanoparticles)
56. Enhancement of the myotic response of rabbits with pilocarpine-loaded polybutylcyanoacrylate nanoparticles
57. Protection induced by inactivated influenza virus vaccines with polymethylmethacrylate adjuvants
58. The use of new polymethylmethacrylate adjuvants for split influenza vaccines
59. Influence of the particle size on the adjuvant effect of paniculate polymeric adjuvants
60. Influence of hydrophobicity on the adjuvant effect of particulate polymeric adjuvants
61. Review: Possibilities of using nanoparticles as carriers for drugs and vaccines
62. Physicochemical characterization of poly-acrylic nanopariicles
63. Evaluation of nanoparticles as drug delivery systems III: Materials, stability, toxicity, possibilities of targeting, and use